blinatumomab
amgen,astellas
['leukemia', 'blinatumomab']
late-break absctracts #ash22 in the phase ill randomized ecog-acrin &amp; nctn trial e1910 study update: blinatumumab was shown to improve os in mrd-negative all patients. 
Mexican Hematologist. Oncohematology; hemostasis and thrombosis. Cruz Azul FC.